𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha interferon for hypereosinophilic syndrome

✍ Scribed by Amando Blanquer; Alfonso Lopez; Fabian Tarín; Fernando Hernandez; Mariano Linares

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
387 KB
Volume
47
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alpha for neurofibromas
Interferon-alpha for neurofibromas
✍ Kebudi, Rejin; Ayan, Inci 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

A twelve-year-old female with neurofibromatosis, presenting with plexiform neurofibromas causing severe pain and in whom relief of pain was achieved after adrninistration of interferon-alpha, is presented.

Imatinib mesylate for lymphocytic varian
Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome
✍ Grzegorz Helbig 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

## Imatinib mesylate for lymphocytic variant of hypereosinophilic syndrome To the editor: With a great interest I read a paper by Christoforidou et al. showing the high efficacy of imatinib mesylate (IM) in a patient with L-HES and undetectable FIP1L1-PDGFRA (F/P) fusion transcript. However, afte

Hypereosinophilic syndrome treated with
Hypereosinophilic syndrome treated with α-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity
✍ Dr. Per Boye Hansen; Hans E. Johnsen; Erik Hippe 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

A 34-year-old male with hypereosinophilic syndrome (HES) and cardiac complications was treated with recombinant human a-interferon (rhlFN) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in the attempt to suppress the eosinophilic cell clones and stimulate the neutrophil myelop

2-Chlorodeoxyadenosine and cytarabine co
2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome
✍ Elias Jabbour; Srdan Verstovsek; Francis Giles; Varsha Gandhi; Jorge Cortes; Sus 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract ## BACKGROUND Hypereosinophilic syndrome (HES) is a rare, disabling, and incurable disease. In this study, a combination of 2‐chlorodeoxyadenosine (2‐CdA) and cytosine arabinoside (ara‐C) chemotherapy was evaluated in patients with HES. ## METHODS Nine patients with HES were treated